MedPath

HOKKAIDO GASTROINTESTINAL CANCER STUDY GROUP

🇯🇵Japan
Ownership
-
Employees
-
Market Cap
-
Website

Phase I / II Study of Irinotecan (CPT-11) Combined With l-Leucovorin (l-LV) and 5-FU in Patients With Advanced Colorectal Cancer

Phase 1
Completed
Conditions
Colorectal Cancer
First Posted Date
2005-09-21
Last Posted Date
2005-09-21
Lead Sponsor
Hokkaido Gastrointestinal Cancer Study Group
Target Recruit Count
23
Registration Number
NCT00209625
Locations
🇯🇵

Hokkaido University Hospital, Sapporo, Hokkaido, Japan

Phase I/II Study of Paclitaxel Plus CPT-11 in Pts. With 2nd Line Chemotherapy of Inoperable or Recurrent GC.

Phase 1
Withdrawn
Conditions
Gastric Cancer
Interventions
Drug: Campt, Topotesin
First Posted Date
2005-09-21
Last Posted Date
2009-02-17
Lead Sponsor
Hokkaido Gastrointestinal Cancer Study Group
Target Recruit Count
40
Registration Number
NCT00209612
Locations
🇯🇵

・ Hokkaido University Hospital (Hokkaido University Graduate School of Medicine / School of Medicine), Sapporo, Hokkaido, Japan

© Copyright 2025. All Rights Reserved by MedPath